Evidence map›Paper›PMID 39673070›Full record

ArticlePopulation health metrics2024

The global burden of disease study and Population Health Metrics.

Grant M A Wyper

Abstract readLetter
In one paragraph

Article in Population health metrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Grant M A WyperClinical and Protecting Health, Public Health Scotland, Glasgow, UK. grant.wyper@phs.scot.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This year marked the launch of the Global Burden of Disease (GBD) 2021 study, the first presentation of the study to incorporate the devastating direct, and indirect, worldwide impacts from the COVID-19 pandemic on population health. Understanding how the study differs from its predecessors is important to inform the innumerable secondary research opportunities from its use. Population Health Metrics prioritise the appraisal of innovative GBD research that moves the dial beyond reporting population health trends already available from the variety of publicly available GBD data visualisations and tools.Burden of disease studies remain a prominent area of research that contribute towards Population Health Metrics achieving its aim of publishing research that informs advances in the science of population health assessment internationally, nationally, and locally. It also remains important that we appraise the gaps in the GBD study, particularly those which are potentially of high impact in policy-influencing discussions. Innovative local and national research has an important role to play in influencing the development of the future GBD study, as well as research which utilises GBD estimates in innovative ways to achieve positive policy impact.

Indexed as

COVID-19Global Burden of DiseaseGlobal HealthPopulation HealthSARS-CoV-2HumansPandemicsBurden of DiseaseGBDGlobal Durden of DiseasePopulation Health Metrics

Identifiers

PMID39673070
PMCPMC11639115

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.